IVERIC bio Overview
Latest P/E ratio for IVERIC bio: -27.55 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow-27.55
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
IVERIC bio (ISEE) currently reports a P/E ratio of -27.55. That is below the Healthcare sector average of 25.9. Use the charts on this page to explore IVERIC bio's P/E ratio history and peer comparisons.
IVERIC bio's P/E ratio of -27.55 is lower than the Healthcare sector average of 25.9. That is roughly 206.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates IVERIC bio's market price to a fundamental measure such as earnings, sales, or book value. At -27.55, ISEE can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of -27.55, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 25.9. From there, open related valuation or income-statement pages for IVERIC bio, and consider following ISEE for alerts when major investors trade the stock.
IVERIC bio is classified in the Healthcare sector. On P/E ratio, it currently shows -27.55 versus a sector average near 25.9. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ISEE with unrelated industries.
